Gaps in Diagnosis and Treatment of Cardiovascular Risk Factors in Patients with Psoriatic Disease: An International Multicenter Study

作者：Eder Lihi; Harvey Paula; Chandran Vinod; Rosen Cheryl F; Dutz Jan; Elder James T; Rahman Proton; Ritchlin Christopher T; Rohekar Sherry; Hayday Richard; Barac Snezana; Feld Joy; Zisman Devy; Gladman Dafna D

来源：Journal of Rheumatology, 2018, 45(3): 378-384.

DOI：10.3899/jrheum.170379

• CARDIOVASCULAR DISEASES
• PSORIATIC ARTHRITIS
• EPIDEMIOLOGY

Objective. We aimed to estimate the proportion of underdiagnosis and undertreatment of cardiovascular risk factors (CVRF) in an international multicenter cohort of patients with psoriasis and psoriatic arthritis (PsA).
Methods. A cross-sectional analysis was conducted of patients with psoriatic disease from the International Psoriasis and Arthritis Research Team cohort. The presence of modifiable CVRF [diabetes, hypertension (HTN), dyslipidemia, smoking, elevated body mass index, and central obesity] and the use of appropriate therapies for HTN and dyslipidemia were determined. The 10-year CV risk was calculated according to the Framingham Risk Score. Physician adherence with guidelines for the treatment of dyslipidemia and HTN was assessed. Regression analysis was used to assess predictors of undertreatment of HTN and dyslipidemia.
Results. A total of 2254 patients (58.9% PsA, 41.1% psoriasis) from 8 centers in Canada, the United States, and Israel were included. Their mean age was 52 +/- 13.8 years and 53% were men. Of the patients, 87.6% had at least 1 modifiable CVRF, 45.1% had HTN, 49.4% dyslipidemia, 13.3% diabetes, 75.3% were overweight or obese, 54.3% central obesity, and 17.3% were current smokers. We found 59.2% of patients with HTN and 65.6% of patients with dyslipidemia were undertreated. Undertreatment was associated with younger age (<= 50 yrs), having psoriasis, and male sex.
Conclusion. In real-world settings, a large proportion of patients with psoriasis and PsA were under-diagnosed and undertreated for HTN and dyslipidemia. Strategies to improve the management of CVRF in psoriatic patients are warranted.

• 出版日期2018-3-1